Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2007
05/18/2007WO2007054215A1 Diaryl ureas for treating pulmonary hypertension
05/18/2007WO2007023111A3 P38 map kinase inhibitors and methods for using the same
05/18/2007WO2007007151A3 Use of anti-mad-cam antibody for the treatment of emphysema
05/18/2007WO2007006544A3 Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
05/18/2007WO2006106438A3 Modulators of ppar activity
05/18/2007WO2006015775A3 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
05/18/2007CA2629375A1 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
05/18/2007CA2629136A1 .alpha.-helix mimetics and method relating to the treatment of cancer stem cells
05/18/2007CA2628849A1 Diaryl urea for treating pulmonary hypertension
05/18/2007CA2628847A1 Diaryl ureas for treating pulmonary hypertension
05/18/2007CA2628472A1 Surfactant protein-d for prevention and treatment of lung infections and sepsis
05/18/2007CA2627726A1 Aerosolformulation for inhalation
05/18/2007CA2627358A1 Heterocyclic modulators of atp-binding cassette transporters
05/18/2007CA2622640A1 Improved process for the preparation of ciclesonide
05/17/2007US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors
05/17/2007US20070112021 Inhibiting gastric acid secretion
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
05/17/2007US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/17/2007US20070111266 Antibodies to murine zcytor17 ligand
05/17/2007US20070110734 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
05/16/2007EP1785422A1 Micronised crystalline tiotropium bromide
05/16/2007EP1785421A1 Tropan compound
05/16/2007EP1785156A1 Pharmaceutical compositions
05/16/2007EP1785136A2 Inhalation medicaments containing an anticholinesterase drug in conjunction with corticosteroid and betamimetic drugs
05/16/2007EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
05/16/2007EP1784224A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
05/16/2007EP1784222A1 Nutritional composition comprising indigestible oligosaccharides
05/16/2007EP1784221A2 Methods for the treatment and prevention of infection using anti-selectin agents
05/16/2007EP1784197A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
05/16/2007EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists
05/16/2007EP1784178A1 Aryl (or heteroaryl) azolylcarbinols
05/16/2007EP1784175A2 Inhibitors of akt activity
05/16/2007EP1615634B1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
05/16/2007EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
05/16/2007EP1169340B1 Lantibiotic
05/16/2007EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy
05/16/2007DE202006005924U1 Zusammensetzung zur Behandlung von Rhinitis Composition for the treatment of rhinitis
05/16/2007CN1964979A Novel water-soluble prodrug
05/16/2007CN1964964A Piperidine derivates for the treatment of chemokines mediared disease
05/16/2007CN1964952A Pyridazin-3(2h)-one derivatives and their use as PDE4 inhibitors
05/16/2007CN1964705A Methods for interfering with fibrosis
05/16/2007CN1962864A Small-interfering RNA inhibiting gene expression of GATA-3 and its coding gene and use
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1961950A Method for preparing Chinese medicinal soft capsule for stopping cough and resolving phlegm and formulation prepared thereby
05/16/2007CN1961944A Chinese medicinal composition for treating cough and asthma
05/16/2007CN1961943A Pharmaceutical composition for treating cold, its preparation method and quality control method thereof
05/16/2007CN1961940A Pure Chinese medicinal granule for treating infant asthma and preparation method thereof
05/16/2007CN1961939A Chinese medicinal composition for clearing heat and removing toxins, its preparation process and quality control method thereof
05/16/2007CN1961927A Pharmaceutical composition for treating acute and chronic inflammation of trachea-bronchia and preparation process thereof
05/16/2007CN1961881A Pharmaceutical composition for treating or preventing respiratory and digestive diseases of birds and livestocks
05/16/2007CN1961867A Granule formulation of montelukast sodium
05/16/2007CN1961762A Sargassum fusiforme alcohol extract and application thereof in tobacco
05/16/2007CN1961761A Sargassum fusiforme aqueous extract and application thereof in tobacco
05/16/2007CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
05/16/2007CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/16/2007CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain
05/16/2007CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/16/2007CN1315835C Polycyclic guanine phosphodiesterase v inhibitors
05/16/2007CN1315833C Azaindole kinase inhibitors
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/16/2007CN1315514C Heat-clearing and detoxicating effervescence tablet and its preparing process
05/16/2007CN1315505C Composition of Chinese traditional medicine curing cough and asthma
05/16/2007CN1315503C Compound Chinese medicine preparation for curing asthma and assisted curing tumor and AIDS and its preparing method
05/16/2007CN1315500C Effervescence tablet of Chinese globeflower and its preparation process
05/16/2007CN1315498C Effervescence tablet for quickly allaying infantile fever and its preparation method
05/16/2007CN1315491C Natural cough stopping oral liquor
05/16/2007CN1315489C New use of fleahane preparation for teating acute respiratory distress syndrome
05/16/2007CN1315486C Effervescence tablet of isatis root and its preparation process
05/16/2007CN1315475C Soft capsule composition of compound cough-relieving and phlegm-eliminating medicine
05/16/2007CN1315466C Durple orange drip pill and its preparation method
05/16/2007CN1315465C Lonicera flower mango drip pill and its preparation method
05/16/2007CN1315462C Throat clearing drip pill and its preparation method
05/15/2007US7217833 May be used to prepare novel aerosol formulations, and can be advantageous in terms of improving the stability of the aerosol formulation, reducing drug deposition, increasing shelf life
05/15/2007US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
05/15/2007US7217738 β2-adrenergic receptor agonists
05/15/2007US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/15/2007US7217732 Cannabinoid receptor agonists
05/15/2007US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses
05/15/2007US7217701 Intracellular calcium concentration increase inhibitors
05/15/2007US7217539 Cell death inducers for mast cells
05/15/2007US7217420 Protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes; formulation comprises a protective amount of live MG strain K5054 or derivatives
05/15/2007US7217409 Suspension stabilizing agents for pharmaceutical aerosols
05/15/2007CA2392973C Benzoimidazole derivatives useful as antiproliferative agents
05/15/2007CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
05/15/2007CA2366186C Retinoid antagonists and use thereof
05/10/2007WO2007053435A1 3 -monosubstituted tropane derivatives as nociceptin receptor ligands
05/10/2007WO2007053082A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma
05/10/2007WO2007051975A2 Compositions comprising igbpma and uses thereof
05/10/2007WO2007029041A3 Interferon lambda therapy for treatment of respiratory diseases
05/10/2007WO2007026358A3 Compositons comprising phosphatidic acid for treatment of eosinophilia and related disorders
05/10/2007WO2007020286A3 Method of using potassium channel inhibiting compounds
05/10/2007WO2007018432A3 Marrubiin and composition for reducing snoring, package and method
05/10/2007WO2007007282A3 Azabicyclo derivatives as muscarinic receptor antagonists
05/10/2007WO2007007281A3 Muscarinic receptor antagonists
05/10/2007WO2007006171A8 A traditional chinese medicine composition, the preparation and quality controlling method thereof
05/10/2007WO2007002701A3 Anti-inflammatory aryl nitrile compounds
05/10/2007US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles